Khalid Shah, MS, PhD.
Vice Chairman of Research, Department of Neurosurgery, Brigham and Women’s Hospital
Khalid Shah, MS, PhD. Read More »
Immuno-Oncology
Paul A. Frohna, MD, PhD, PharmD
Chief Medical & Scientific Officer, ImCheck Therapeutics
Paul A. Frohna, MD, PhD, PharmD Read More »
Lisa Vervueren, MD
Pharmaceutical expert, NIHDI (Belgium), HTA Taskforce Beneluxa Initiative.
Lisa Vervueren, MD Read More »
Jon A Kyte MD PhD
Head, Department of Clinical Cancer Research, Research Group Leader, Department of Cancer Immunology, Oslo University Hospital
Alexander M.M. Eggermont, MD, PhD
Prof Immunotherapy University Medical Center Utrecht, Comprehensive Cancer Center Munich
Alexander M.M. Eggermont, MD, PhD Read More »
Ivan Diaz-Padilla, MD, PhD
Vice-President, Oncology Clinical Development, Global Head, Immuno-Oncology, GSK
Ivan Diaz-Padilla, MD, PhD Read More »
Prof. Anders Ståhlberg
Professor in Clinical Genomics, is working as principal investigator at Sahlgrenska Center for Cancer Research
Prof. Anders Ståhlberg Read More »
Hans van der Vliet, MD PhD
Scientific founder and Chief Scientific Officer of LAVA Therapeutics
Hans van der Vliet, MD PhD Read More »
